Vascular complications in relation to ethnicity in non-insulin-dependent diabetes mellitus

European Journal of Clinical Investigation

Volumn 27, Issue 3, 1997, Pages 182-188

  Weijers, R N M ^a   Goldschmidt, H M J ^b   Silberbusch, J ^b  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b NONE

Author keywords

age; duration of diabetics; ethnicity; macrovascular complications; microvascular complications; non insulin dependent diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ETHNOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0030888951     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.840637.x     Document Type: Article

References (35)

1. Tooke JE, Shore AC. The regulation of microvascular function in diabetes mellitus. In: Pickup JC, Williams G, eds. Textbook of Diabetes. London: Blackwell Scientific Publications, 1991: 546-52.
2. Jarrett RJ, Keen H, Grabauskas V. The WHO multinational study of vascular disease in diabetes. Diabetes Care 1979;2:175-201.
3. Mandarino LM. Current hypotheses for the biochemical basis of diabetic retinopathy. Diabetes Care 1992;15:1892-901.
4. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992;15:815-19.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
6. Mykkäen L, Haffner SM, Kuusisto J, Pyorälä K, Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes 1994;43:552-7.
7. Dodson PM. Dyslipidaemia and diabetes: an introduction. In: Dodson PM, Barnett AH, eds. Lipids, Diabetes and Vascular disease. London: Science Press, 1992: 1-15.
8. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-6.
9. Fontbonne A, Papoz L, Eschwege E, Roger M, Saint-Paul M, Simon D. Features of insulin-resistance syndrome in men from French Caribbean islands. Diabetes 1992;41:1385-9.
10. Haffner SM, Miettinen H, Stern M. Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic Whites with parental history of diabetes. J Clin Endocrinol Metab 1996;81:1846-51.
11. Simmons D, Shaw LM, Scott DJ, Kenealy T, Scragg RK. Diabetic nephropathy and microalbuminuria in the community. Diabetes Care 1994;17:1404-10.
12. Pacy PJ, Dodson PM, Kubicki AJ, Fletcher RF. Differences in lipid and lipoprotein levels in white, black and asian non-insulin dependent (type 2) diabetics with hypertension. Diabetes Res 1987;4:187-93.
13. Siedel J, Hägele EO, Ziegenhom J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-80.
14. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-4.
15. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidasecoupled method for the determination of serum triglycerides. Clin Chem 1983;29:538-42.
16. Bartels H, Böhmer M, Heierli C. Serum Kreatininbestimmung ohne enteiweissen. Clin Chim Acts 1972;37:193-7.
17. Hilborne LH, Lin PC, Higgins SA, Rodgerson DO. Evaluation of the Behring nephelometer for detection of low level urinary albumin. Am J Clin Pathol 1990;93:405-10.
18. Rowe DJF, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albunin in urine. Ann Clin Biochem 1990;27:297-312.
19. Delahunty T. Convenient screening for hemoglobin variants by using the Diamat HPLC System. Clin Chem 1990;36:903-5.
20. WHO Study Group. Diabetes Mellitus. Report of a WHO Study Group, Technical Report Series 727. WHO: Geneva, 1985.
21. Study Group of the European Atherosclerosis Society. The recognition and management of hyperlipidemia in adults: a policy statement of the European Atherosclerosis Society. Eur Heart J 1988;9:571-600.
22. Shepherd J, Betteridge DJ, Durrington P et al. Strategies for reducing heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidemia Association. Br Med J 1987;295:1245-6.
23. Schlant RC, Wayne Alexander R. Diagnosis and management of chronic ischemic heart disease. In: Wayne Alexander R, Schlant RC, eds. The Heart. New York, McGraw-Hill, 1993: 1055-82.
24. Fonville TC, Janssen MFM, Klip RP. De trentbreuk. In: Trendbreuk Informatie Etnische Groepen in Amsterdam, Amsterdam. 1994: 15-36.
25. Stata Corporation: Stata Reference Manual: Release 3.1. 6th edn. Stata Corporation, College Station, TX. 1993.
26. Weber B, Burger W, Hartman R, Hovener G, Malchus R, Oberdisse U. Risk factors for the development of retinopathy in childern and adolescents with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1986;29:23-9.
27. Klein BE, Klein R, Moss SE, Palta M. A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol 1995;113:601-6.
28. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-66.
29. Danne T, Weber B, Hartmann R, Enders I, Burger W, Hovener G. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Diabetes Care 1994;17:1390-96.
30. Fontbonne A, Eschwège E, Cambien F et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 1989;32: 300-4.
31. Dubois D, Chanson P, Timsit J et al. Remission of proteinuria following correction of hyperlipidemia in NIDDM patients with nondiabetic glomerulopathy. Diabetes Care 1994;17:906-8.
32. Stiegler H, Standl E, Standl R et al. Risk profile and macroangiopathy in type II diabetics in medical practice. Vasa 1990;19:119-28.
33. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in eldery subjects. Diabetes 1994;43:960-7.
34. Beks PJ, Mackaay AJC, de Neeling JND, de Vries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycaemic level in an elderly Caucasien population: the Hoorn study. Diabetologia 1995;38:86-96.
35. Cohn PF, Braunwald E. Chronic ischemic heart disease. In: Braunwald E, ed. Heart disease. Philadelphia: Saunders, 1984: 1334-83.